All studies
AuthorisedTherapeutic use (Phase IV)Interventional

BEAT Fatigue – Benefit of Elevated Administration of Thiamine for Fatigue in Rheumatoid Arthritis: A randomized, double-blind, placebo-controlled trial

Severe tiredness, or fatigue, is a major problem for many people living with rheumatoid arthritis. Even when joint swelling is under control, feeling completely drained of energy can make daily life very difficult. This trial is testing whether taking a high-strength dose of vitamin B1 (also known as thiamine) can help boost energy levels. Researchers are comparing 300 mg vitamin B1 tablets with a dummy pill (placebo) that looks identical but contains no active medicine. Participants take the tablets for four weeks. During this time, doctors will track changes in physical, mental, and emotional tiredness, as well as joint pain, stiffness, and general well-being. The goal is to find out if this simple, widely available vitamin could offer a safe, new way to help manage rheumatoid arthritis fatigue.

At a glance

Status
Authorised
Phase
Therapeutic use (Phase IV)
Sponsor
Odense University Hospital
Enrolment target
150
Start
12 Jun 2026

What is this study about?

Rheumatoid arthritis is a long-term condition that causes pain, swelling, and stiffness in the joints. However, one of the most exhausting symptoms people face is severe fatigue. This is not ordinary tiredness that gets better with a good night's sleep; it is a deep, overwhelming lack of energy that can affect work, family life, and mental well-being. Currently, there are very few treatments that directly target this kind of fatigue.

This clinical trial, called the BEAT Fatigue study, is exploring whether high doses of thiamine can make a meaningful difference. Thiamine, also known as vitamin B1, plays an essential role in how our bodies turn food into energy. Some early research suggests that extra thiamine might help people with long-term illnesses feel more energetic and better able to cope with everyday tasks.

In this study, researchers will compare the effects of taking 300 mg of vitamin B1 daily against a dummy pill, known as a placebo. Because the trial is 'double-blind', neither the participants nor the research team will know who is taking the real vitamin and who is taking the placebo until the end. This helps ensure the results are completely fair and reliable.

By carefully measuring fatigue, joint swelling, and overall health over four weeks, researchers hope to see if thiamine is an effective treatment. If successful, it could provide doctors and patients with an affordable, easy-to-use option to tackle one of the most challenging symptoms of rheumatoid arthritis.

Key takeaways

  • Tests whether high-dose vitamin B1 (thiamine) reduces severe tiredness in rheumatoid arthritis.
  • Compares a 300 mg daily vitamin tablet with a dummy pill (placebo) over four weeks.
  • Open to adults aged 18 and over living with rheumatoid arthritis and fatigue.
  • Monitors joint swelling, pain levels, and physical and emotional energy.
  • Participation is voluntary, and you can withdraw at any point without affecting your care.

Who may be eligible?

This trial is open to adults aged 18 and over who have been diagnosed with rheumatoid arthritis and are experiencing persistent fatigue. Both men and women can take part.

To join, participants must be willing to take daily tablets for four weeks and complete questionnaires about their symptoms. Because this is a research study, the medical team will need to check your medical history to make sure taking high-dose vitamin B1 is safe for you.

Certain people may not be able to participate—for example, anyone who has an allergy to vitamin B1 supplements or who is already taking high-dose thiamine. Your study doctor will review all your current medications and health conditions before confirming whether you can take part.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or older.
  2. I have a confirmed diagnosis of rheumatoid arthritis.
  3. I struggle with persistent, disruptive tiredness or fatigue.
  4. I am able and willing to take a daily tablet for four weeks.
  5. I can attend clinic visits and complete surveys about my symptoms.
Answer every question to see your result.

What does participation involve?

If you decide to take part, your involvement will last for about four weeks. At the start of the study, you will have an initial assessment where the team checks your joints, takes a small blood sample to measure inflammation, and asks you to fill out questionnaires about your energy levels, pain, and daily activities.

You will then be given a four-week supply of tablets to take at home. You will receive either the high-strength vitamin B1 (300 mg) or an identical-looking dummy pill (placebo). A computer decides which treatment you receive by chance.

During the four weeks, you may be asked to keep track of how you feel. At the end of the month, you will attend a follow-up appointment to repeat the questionnaires, have your joints checked again, and review any changes in your fatigue and general well-being.

Potential risks and benefits

Taking part may help improve your fatigue and daily energy, though this cannot be guaranteed as you might receive the dummy pill. The findings could also help improve care for other people with rheumatoid arthritis in the future. Vitamin B1 is generally very safe because any excess is usually passed out naturally in urine, but mild side effects like an upset stomach can occasionally occur. You are free to leave the study at any time without giving a reason, and doing so will not affect your normal NHS care or relationship with your medical team.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Denmark

Common questions

What is a placebo?

A placebo is a dummy tablet that looks, smells, and tastes just like the real medicine, but contains no active ingredients. It helps researchers see if changes are truly caused by the vitamin.

Will I know if I am taking the vitamin or the dummy pill?

No. Neither you nor your study doctor will know which tablet you are taking during the study. This ensures the results are completely unbiased.

Can I carry on taking my normal arthritis medications?

In most cases, yes. You should continue your usual prescribed treatments, but you must tell the study team about everything you take, including over-the-counter supplements.

Is 300 mg of vitamin B1 safe?

Vitamin B1 is water-soluble, meaning the body does not store large amounts and passes any extra out in your urine. High doses are generally considered safe and well-tolerated.

Do I have to pay to take part?

No, clinical trials do not charge participants. The study medication, clinic visits, and all trial-related tests are provided free of charge.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.